Myeongmun Cefixime Capsule 100mg (Cefixime Trihydrate)

Adult dose

(Capsules) ○ Adults: Administer 50～100mg (potency) of cefixime orally twice daily. For severe infections or inadequate response, administer 200mg (potency) twice daily. Adjust the dose appropriately according to age and symptoms.

Child dose

(Capsules) ○ Children weighing 30 Kg or more: Administer 50～100mg (potency) of cefixime orally twice daily. For severe infections or inadequate response, administer 200mg (potency) twice daily. Adjust the dose appropriately according to age and symptoms. (Powder) ○ Children: Administer 1.5～3mg (potency) of cefixime per Kg of body weight orally twice daily. For severe infections or inadequate response, administer 6mg (potency) per Kg of body weight twice daily. Adjust the dose appropriately according to age and symptoms.

This medication should not be used in patients who have previously experienced severe allergic reactions or shock due to this drug. Patients allergic to other antibiotics in the cephalosporin class should also avoid this medication for safety. Caution should be taken when administering to patients with a history of allergic reactions or hypersensitivity to penicillin antibiotics. Patients with asthma, skin rashes, or urticaria should be monitored carefully. In patients with severely reduced kidney function, the concentration of this medication may increase, so dosage should be adjusted and the dosing interval extended. Patients who have difficulty with oral intake, those on non-oral nutrition, the elderly, and those with poor overall health should be carefully monitored for symptoms of vitamin K deficiency. This medication can rarely cause severe shock or anaphylaxis, so if symptoms such as discomfort, breathing difficulties, or rashes occur, administration should be stopped immediately and appropriate treatment should be given. Gastrointestinal side effects may include diarrhea, abdominal pain, and vomiting; especially if severe diarrhea or abdominal pain occurs, the medication should be stopped immediately and the physician consulted. If any abnormal respiratory symptoms appear, administration should also be stopped, and appropriate treatment is necessary. Abnormal blood symptoms or liver dysfunction and impaired renal function may occur, thus regular testing is necessary, and if abnormalities are found, use should be discontinued. Severe skin rashes or toxic epidermal necrolysis may occur, and serious skin reactions such as Stevens-Johnson syndrome should lead to immediate discontinuation of this medication if symptoms are observed. This medication may inhibit the production of vitamin K, which can affect blood coagulation, so caution is necessary when used with anticoagulants like warfarin. Additionally, caution should be exercised when used with other drugs that are nephrotoxic, as they may burden the kidneys. Women who are pregnant or may become pregnant should only use this medication if necessary and under a physician's judgment, as its safety has not been established. It is advisable to avoid breastfeeding during the period of taking this medication. It is not recommended for use in neonates, premature infants, and infants less than 6 months old, as safety has not been established. Elderly patients may experience side effects more readily due to decreased bodily function, so dosage and administration intervals should be adjusted with careful observation. This medication may affect some clinical test results, so it is important to inform healthcare personnel of its use during testing. Finally, to prevent the emergence of resistant bacteria, it is advisable to use this medication only for the appropriate duration determined by susceptibility testing.

• Shock
• discomfort
• oral dysesthesia
• wheezing
• dizziness
• stool changes
• tinnitus
• sweating
• dyspnea
• generalized flushing

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance

A light orange hard capsule containing a white to light yellow crystalline powder.

Package unit

30 capsules/bottle, 100 capsules/bottle, 300 capsules/bottle